Mycosis fungoides has no cure unless doctors can diagnose it in the earliest stage. At this point, people have a 95% survival rate over 10 years, according to a 2022 research review .

Mycosis fungoides is a chronic condition that can slowly worsen over time. Like other cancers, it can spread to other parts of the body in later stages, like the digestive system, liver, or brain.

During stage 4, mycosis fungoides may spread throughout the body to other organs. The liver and spleen may become enlarged. At times, the heart muscle may be affected as well.

Mycosis fungoides is rarely cured, but some people stay in remission for a long time. In early stages, it's often treated with medicines or therapies that target just your skin.

Mycosis fungoides is often difficult to diagnose in the earliest stages because it mimics benign eruptions such as eczema or psoriasis. These conditions are all characterized by red, scaly, itchy ...

Topical synthetic hypericin ointment, activated with visible light, shows efficacy in reducing mycosis fungoides-cutaneous T-cell lymphoma lesions, according to a phase 3 study.“This trial ...

Objective: Three patients with follicular mycosis fungoides (FMF), a rare variant of folliculotropic cutaneous T-cell lymphoma, are discussed. Follicular involvement in cutaneous T-cell lymphoma ...

Nevertheless, according to a recent intriguing report, 97 percent of patients with late-stage mycosis fungoides or the Sézary syndrome are seropositive for cytomegalovirus, in contrast to healthy ...

The mycosis fungoides market is set to project sublime growth at a compounded annual growth rate (CAGR) of 4.9% during the forecast period from 2021 to 2029.

Most cases of mycosis fungoides are early stage and are diagnosed in patients over the age of 50. About Ceptaris Therapeutics. Ceptaris Therapeutics, Inc. is a privately held, specialty ...

Patients with histologically early plaque-stage folliculotropic mycosis fungoides had similar overall survival to patients with patches or follicular papules, and patients with advanced plaque ...